Clinical trial
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment…
NCT00094497 · Collaborative Group for Adrenocortical Carcinoma Treatment, Other · Completed
Key facts
| NCT number | NCT00094497 |
|---|---|
| Title | Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) |
| Official title | First International Randomized Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment |
| Lead sponsor | Collaborative Group for Adrenocortical Carcinoma Treatment, Other |
| Collaborators | German Federal Ministry of Education and Research National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma, Adrenal Cortical |
| Intervention type | Drug |
| Interventions | Etoposide, Doxorubicin, Cisplatin, Streptozotocin, Mitotane |
| Enrollment | 304 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Oct 20, 2004 |
| Last update posted | Sep 21, 2016 |
| Countries | Australia, Austria, France, Germany, Italy, Netherlands, Sweden, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: